About Michael S. Saag
Michael S. Saag is a physician and prominent HIV/AIDS researcher at the University of Alabama at Birmingham. He holds the Jim Straley Chair in AIDS Research, is Director of the Division of Infectious Disease and of the William C. Gorgas Center for Geographic Medicine, and Director of the Center for AIDS Research.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Michael S. Saag
During the past decade, Michael S. Saag conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery
2005-01-01
2006-07-01
Unknown status
220
PREVAIL-TA: Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe)
2009-09-01
2016-03-01
Completed
220
Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter
2012-02-01
2015-06-01
Completed
146
Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery
2014-08-01
2015-07-01
Completed
75
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Michael S. Saag
According to Clinical.Site data, the most researched conditions in "Michael S. Saag" are
"HIV Infections" (2 trials). Many other conditions were trialed in "Michael S. Saag" in a lesser frequency.
Clinical Trials Intervention Types at Michael S. Saag
Most popular intervention types in "Michael S. Saag" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Indinavir sulfate" (1 trials), "Lamivudine" (1 trials), "Nelfinavir mesylate" (1 trials) and "Stavudine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Michael S. Saag
The vast majority of trials in "Michael S. Saag" are
2 trials for "All" genders.
Clinical Trials Status at Michael S. Saag
Currently, there are NaN active trials in "Michael S. Saag".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Michael S. Saag,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Michael S. Saag, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".